title: Epstein-Barr virus-specific adoptive immunotherapy: a new horizon for multiple sclerosis treatment?
authors.affiliation: The University of Queensland, School of Medicine, Brisbane, Queensland, Australia.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Pender
authors.forename: Rajiv
authors.initials: R
authors.lastname: Khanna
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D019264:Adoptive Transfer / Q000379:methods*; D000328:Adult; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000637:transplantation*; D002454:Cell Differentiation / Q000276:immunology; D049109:Cell Proliferation; D018984:Epitopes, T-Lymphocyte / Q000235:genetics / Q000276:immunology; D019309:Epstein-Barr Virus Nuclear Antigens / Q000235:genetics / Q000276:immunology; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D016896:Treatment Outcome; D014763:Viral Matrix Proteins / Q000235:genetics / Q000276:immunology; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D018984:Epitopes, T-Lymphocyte; D019309:Epstein-Barr Virus Nuclear Antigens; D014763:Viral Matrix Proteins; D014764:Viral Proteins; C417029:EBV-encoded nuclear antigen 1
keywords: B cell; CD8 T cell; Epstein–Barr virus; adoptive immunotherapy; multiple sclerosis; treatment